Novartis Ag (NVSEF) Inventory (2009 - 2025)

Novartis Ag has disclosed Inventory across 14 years of filings, most recently posting $6.3 billion for Q4 2025.

• Inventory for Q4 2025 came in at $6.3 billion, up 9.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.3 billion (up 9.54% YoY), and the FY2025 annual result was $6.3 billion, up 9.54% from the prior year.
• Inventory came in at $6.3 billion for Q4 2025 at Novartis Ag, down from $6.3 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $8.2 billion in Q2 2023 to a low of $5.7 billion in Q4 2024.
• The 5-year median for Inventory is $6.5 billion (2021), against an average of $6.6 billion.
• Across the five-year window, Inventory jumped 8365.48% in 2021 and slumped 30.15% in 2024, its largest moves.
• Novartis Ag's Inventory stood at $6.7 billion in 2021, then climbed by 7.64% to $7.2 billion in 2022, then slipped by 17.59% to $5.9 billion in 2023, then dropped by 3.21% to $5.7 billion in 2024, then advanced by 9.54% to $6.3 billion in 2025.
• The last three Inventory figures came in at $6.3 billion (Q4 2025), $6.3 billion (Q2 2025), and $5.7 billion (Q4 2024), per Business Quant data.